Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease

被引:94
|
作者
Cahill, M
Karabatzaki, M
Meleady, R
Refsum, H
Ueland, P
Shields, D
Mooney, D
Graham, I
机构
[1] Royal Victorian Eye & Ear Hosp, Res Fdn, Dublin 2, Ireland
[2] Adelaide Meath Hosp, Natl Childrens Hosp, Dept Cardiol, Dublin 24, Ireland
[3] Univ Bergen, Dept Pharmacol, N-5021 Bergen, Norway
[4] Royal Coll Surgeons Ireland, Dept Clin Pharmacol, Dublin 2, Ireland
关键词
D O I
10.1136/bjo.84.2.154
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background/aims-A moderately elevated plasma concentration of the sulphur amino acid homocysteine is an independent risk factor for atherosclerotic vascular disease. Many of the risk factors associated with coronary, cerebral, and peripheral atherosclerotic vascular disease are common to retinal vascular occlusive disease but it is unclear whether elevated plasma concentrations of homocysteine are also associated with such disease. This study assessed the relation between retinal vascular occlusive disease and elevated levels of plasma total homocysteine (tHcy). Methods-A retrospective case-control study involving hospital based controls and cases with retinal artery, central retinal vein (including hemiretinal vein), and branch retinal vein occlusions was performed. The relation between elevated tHcy, defined as a level greater than or equal to 12 mu mol/l and risk of retinal vascular occlusive disease was examined. Results-87 cases of retinal vascular occlusive disease including 26 cases of retinal artery occlusion, 40 cases with central retinal vein occlusion, and 21 cases of branch retinal vein occlusion were compared with 87 age matched controls. Mean tHcy levels were higher in all disease groups and this difference was significant in patients with retinal artery occlusions (p = 0.032) and patients with central retinal vein occlusion (p = 0.0001). When adjusted for known cardiovascular risk factors, tHcy was an independent risk factor for retinal vascular occlusive disease (OR 2.85 (95% CI 1.43-5.68)). Conclusions-Elevated tHcy is an independent risk factor for retinal vascular occlusive disease. Assessment of tHcy may be important in the investigation and management of patients with retinal vascular occlusive disease.
引用
收藏
页码:154 / 157
页数:4
相关论文
共 50 条
  • [41] Thermolabile MTHFR genotype and retinal vascular occlusive disease
    Cahill, M
    Karabatzaki, M
    Donoghue, C
    Meleady, R
    Mynett-Johnson, LA
    Mooney, D
    Graham, IM
    Whitehead, AS
    Shields, DC
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2001, 85 (01) : 88 - 90
  • [42] Elevated plasma homocysteine level as a risk factor for coronary artery disease
    Dzielinska, Z
    Kadzìela, J
    Dabrowski, M
    Sitkiewicz, D
    Kruk, M
    Przyluski, J
    Deptuch, T
    Ruzyllo, W
    EUROPEAN HEART JOURNAL, 2000, 21 : 455 - 455
  • [43] Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.
    Seshadri, S
    Beiser, A
    Selhub, J
    Jacques, PF
    Rosenberg, IH
    D'Agostino, RB
    Wilson, PWF
    Wolf, PA
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (07): : 476 - 483
  • [44] Plasma homocysteine: an independent or an interactive risk factor for coronary artery disease
    Gupta, M
    Sharma, P
    Garg, G
    Kaur, K
    Bedi, GK
    Vij, A
    CLINICA CHIMICA ACTA, 2005, 352 (1-2) : 121 - 125
  • [45] Homocysteine and the brain: vascular risk factor or neurotoxin?
    Seshadri, S
    Wolf, PA
    LANCET NEUROLOGY, 2003, 2 (01): : 11 - 11
  • [46] Homocysteine -: A treatable risk factor for allograft vascular disease after heart transplantation?
    Kutschka, I
    Pethig, K
    Strüber, M
    Dieterich, C
    Harringer, W
    Haverich, A
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2001, 20 (07): : 743 - 746
  • [47] Homocysteine: A treatable risk factor for allograft vascular disease after heart transplantation
    Kutschka, I
    Pethig, K
    Strueber, M
    Dieterich, C
    Haverich, A
    CIRCULATION, 1999, 100 (18) : 163 - 163
  • [48] Plasma homocysteine and vascular disease in psychogeriatric patients
    Nilsson, K
    Gustafson, L
    Hultberg, B
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2006, 21 (03) : 148 - 154
  • [49] Elevated plasma homocysteine and diabetic vascular disease
    Colwell, JA
    DIABETES CARE, 1997, 20 (12) : 1805 - 1806
  • [50] Clinical usefulness of plasma homocysteine in vascular disease
    Hankey, GJ
    Eikelboom, JW
    Ho, WK
    van Bockxmeer, FM
    MEDICAL JOURNAL OF AUSTRALIA, 2004, 181 (06) : 314 - +